OBERMANNOVA, R., Martina LOJOVÁ, Petra VYCHYTILOVÁ, P. GRELL, W.C. CHO, M. SACHLOVA, M. SVOBODA, R. VYZULA and Ondřej SLABÝ. Tumor Expression of miR-10b, miR-21, miR-143 and miR-145 Is Related to Clinicopathological Features of Gastric Cancer in a Central European Population. Anticancer Research. Athens: International Institute of Anticancer Research, vol. 38, No 6, p. 3719-3724. ISSN 0250-7005. doi:10.21873/anticanres.12651. 2018.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Tumor Expression of miR-10b, miR-21, miR-143 and miR-145 Is Related to Clinicopathological Features of Gastric Cancer in a Central European Population
Authors OBERMANNOVA, R. (203 Czech Republic), Martina LOJOVÁ (203 Czech Republic, belonging to the institution), Petra VYCHYTILOVÁ (203 Czech Republic, belonging to the institution), P. GRELL (203 Czech Republic), W.C. CHO (344 Hong Kong), M. SACHLOVA (203 Czech Republic), M. SVOBODA (203 Czech Republic), R. VYZULA (203 Czech Republic) and Ondřej SLABÝ (203 Czech Republic, guarantor, belonging to the institution).
Edition Anticancer Research, Athens, International Institute of Anticancer Research, 2018, 0250-7005.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher Greece
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.935
RIV identification code RIV/00216224:14740/18:00106974
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.21873/anticanres.12651
UT WoS 000449934200066
Keywords in English Gastric cancer; microRNA; diagnosis; prognosis
Tags Excelence Science, MU, RIV, rivok, user
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 21/3/2019 09:41.
Abstract
Background/Aim: In Western countries, most patients with gastric cancer (GC) present in advanced stages. Therefore, there is imminent clinical need for novel diagnostic and prognostic biomarkers. Deregulation of microRNAs has been reported as a frequent event in GC development in a number of studies. Our study validated the potential of microRNAs to serve as diagnostic and prognostic biomarkers in patients with GC from the Central European population. Materials and Methods: Using quantitative real-time polymerase chain reaction, expression levels of six microRNAs (miR-10b, -21, -93, -107, - 143 , and -145) were examined in 67 tumor tissues and 67 paired adjacent gastric tissues, and correlated with clinicopathological features of GC patients. Results: Expression levels of miR-10b, miR-21, miR-93 , and miR-107 were significantly higher in GC samples compared to non-tumor tissue. Furthermore, the expression levels of miR-10b, miR-143, and miR-145 positively correlated with advanced stages, and increased expression of miR-10b, miR-21 and miR-145 was significantly associated with worse prognosis of gastric cancer patients. Conclusion: Our results indicate that selected tissue microRNAs have the potential to serve as relevant diagnostic and prognostic biomarkers of GC in a central European population.
Links
NV17-29389A, research and development projectName: Sekvenční FDG-PET a miRNA jako biomarker změny strategie předoperační léčby u lokálně pokročilého karcinomu žaludku a gastroesofageální junkce
PrintDisplayed: 16/4/2024 20:34